Skip to content

Efficacy of Transcranial Magnetic Stimulation in children with Autism Spectrum Disorder

Study to determine efficacy of repetitive Transcranial Magnetic Stimulation (RTMS) in children with Autism Spectrum Disorder: A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017568
Enrollment
60
Registered
2019-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Transcranial Magnetic Stimulation: Pre-Intervention preparation: (a) Clinical evaluation by investigator with emphasis on vital parameters, hydration status (b) Sedation, if required,

Sponsors

Vishal Sondhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) Indian Scale for Assessment of Autism Scores 70 or more (b) Either parent should be willing and capable of following instructions and maintaining activity log

Exclusion criteria

Exclusion criteria: (a) History of seizure(s) in child or immediate (1st degree relative) family (b) Abnormal EEG (c) Secondary autism (as a co-morbidity of structural brain lesion, metabolic cause etc) (d) Children with concomitant chronic systemic illnesses that can interfere with administration of intervention (e) Children with any acute illness (f) Children with history of fainting spells (g) Children with metallic implants, pacemaker, VP shunt, Vagal Nerve Stimulator, Deep Brain Stimulator (h) Dysmorphism involving head (i) History of severe head injury (j) Progressive neurological illness (k) Children on medicines that decrease seizure threshold (eg. Baclofen)

Design outcomes

Primary

MeasureTime frame
To compare 6-16-year-old children and adolescents with Autism Spectrum Disorder (ASD) (Indian Scale for Assessment of Autismâ?¥ 70) managed with repetitive Transcranial Magnetic Stimulation (rTMS) once a week for twelve weeks with those managed with identical dosage of placebo, for change in Childhood Autism Rating Scale-2 (CARS-2) scores at 12 weeks of completion of interventionTimepoint: At 12 weeks of completion of intervention

Secondary

MeasureTime frame
To compare 6-16-year-old children and adolescents with Autism Spectrum Disorder (ASD) (Indian Scale for Assessment of Autism â?¥ 70) managed with repetitive Transcranial Magnetic Stimulation (rTMS) once a week for twelve weeks with those managed with identical dosage of placebo, for change in Indian Scale for Assessment of Autism Scores at 12 wks of completion of interventionTimepoint: 12 wks of completion of intervention;To compare 6-16-year-old children and adolescents with Autism Spectrum Disorder (ASD) (Indian Scale for Assessment of Autism â?¥ 70) managed with repetitive Transcranial Magnetic Stimulation (rTMS) once a week for twelve weeks with those managed with identical dosage of placebo, for change inSocial Communication Questionnaire (SCQ) Scores Timepoint: 12 weeks from completion of rTMS;To compare 6-16-year-old children and adolescents with Autism Spectrum Disorder (ASD) (Indian Scale for Assessment of Autism â?¥ 70) managed with repetitive Transcranial Magnetic Stimulation (rTMS) once a week for twelve weeks with those managed with identical dosage of placebo, for change into compare the change in the Childhood Autism Rating Scale-2 (CARS-2) scores between children in the two groups at 6 months of completion of intervention. Timepoint: 6 months of completion of intervention

Countries

India

Contacts

Public ContactVishal Sondhi

Armed Forces Medical College

vishalsondhi@gmail.com9560664032

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026